News related to
China

Kyiv’s parliament has introduced draft Bill 13356, empowering the National Bank of Ukraine to incorporate virtual assets—primarily Bitcoin—into its official gold and foreign-exchange reserves. The legislation would not compel the central bank to adopt such assets, but merely grant it the legal framework to do so.

Lead author Yaroslav Zheleznyak, first deputy chair of the Rada’s Finance Committee, highlighted that the bank would retain full discretion over timing, volume, and methodology of any crypto acquisitions. He described the measure as a pivotal move to “integrate Ukraine into global financial innovations” and bolster macroeconomic resilience while catalysing the digital economy.

Ukraine currently holds approximately 46,351 BTC—valued at over $5 billion—though these holdings originate from asset seizures, donations, and fundraising during wartime, and remain under civil-servant control rather than central-bank custody. If passed, the law would permit the bank to transition some of those coins into officially recognised reserves.

The proposal mirrors a broader trend: several nations are charting similar initiatives. The United States launched a Strategic Bitcoin Reserve under an executive order issued on 6 March by former President Trump, consolidating government‑owned cryptos into a national asset. Pakistan, Brazil and the Czech Republic are exploring mechanisms to incorporate digital assets into sovereign financial systems. El Salvador, which adopted Bitcoin as legal tender in 2021, holds over 6,000 BTC, while Bhutan maintains mining‑powered reserves worth around $750 million.

Yet the move is not without detractors. Critics emphasise Bitcoin’s volatility, liquidity constraints and concentration within corporate entities like MicroStrategy, which undermine its suitability as a stable reserve asset. The Swiss National Bank’s governor, Martin Schlegel, reaffirmed this stance on 25 April in Bern, warning that crypto lacks the stability and liquidity required for central‑bank reserve portfolios. ECB President Christine Lagarde has echoed similar concerns, stating that digital assets do not meet the criteria for eurozone reserve holdings.

Proponents argue that strategic inclusion could buffer Ukraine against inflation and currency devaluation, offering rapid, secure transferability unmatched by physical assets. Zheleznyak’s Telegram statement emphasised that implementation would be fully at the central bank’s professional discretion.

Operationalising the proposal will require establishing robust legal and procedural frameworks: anti‑money‑laundering protocols, cybersecurity safeguards, digital custody infrastructure, and accounting mechanisms. Banking analysts suggest that careful integration and risk management will be essential to balance innovation with financial stability.

Ukraine’s draft arrives amid growing global debate on digital money. Central bank digital currencies are being piloted worldwide, such as Turkey’s digital lira, China’s e‑renminbi, and Nigeria’s e‑Naira. Meanwhile, debates continue over whether public‑sector balance sheets should venture into decentralised finance or maintain traditional gold‑forex portfolios.

As parliamentarians prepare to debate Bill 13356, attention will turn to amendments that might specify asset types, risk parameters, and accounting standards—or narrow discretionary power for the central bank. The legislation must also align with IMF frameworks and comply with anti‑money‑laundering regulations.

Donald Trump has declared on social media that the United States and China have finalised a trade agreement, pending formal sign-off from both himself and Chinese President Xi Jinping. The accord ensures China will supply rare earth minerals and magnets “up front” to the U.S., while the U.S. will honour its commitments, including allowing Chinese students to study at American universities. Trump also highlighted a tariff arrangement favouring the U.S., imposing a total of 55 per cent, against China’s 10 per cent.

Negotiators in London laid the groundwork for this framework during two days of discussions aimed at restoring the Geneva truce first reached in May, which had faltered amid export restrictions on critical minerals. U.S. Commerce Secretary Howard Lutnick described the outcome as putting “meat on the bones” of the Geneva agreement by addressing China’s curbs on rare earths and magnets. Both governments intend to present the framework for approval by Trump and Xi.

China controls a significant share of the world’s rare earth minerals, essential for manufacturing electronics, electric vehicles and defence technologies. Export licences recently granted to Chinese firms meeting U.S. demand reinforce China’s commitment to the agreement. The shortage of these minerals had previously disrupted global supply chains and limited U.S. access to critical components.

Alongside rare earth supplies, the agreement addresses educational exchanges by reaffirming that Chinese students will continue to access American universities. Trump emphasised this pledge in his social media announcement. Although the U.S. has criticised visas for students in sensitive fields, the deal appears to restore earlier norms.

Trump presented the tariff structure as a win for American interests: 55 per cent U.S. tariffs versus 10 per cent Chinese tariffs. These adjustments mark a shift from the extreme tariff stances of earlier this year, which had peaked at triple-digit levels.

Stock markets responded cautiously to the news: global indices displayed measured optimism as investors awaited details and official approvals. Analysts warned that markets remain fragile, with movement dependent on implementation and trust between the two nations.

Beijing’s participation was led by Vice Premier He Lifeng and Commerce Minister Wang Wentao, who conveyed the deal as a balanced step toward reviving the Geneva pact. The U.S. delegation included Commerce Secretary Lutnick, Treasury Secretary Scott Bessent, and Trade Representative Jamieson Greer. President Trump and President Xi had previously spoken by telephone on 5 June, building momentum for these discussions.

Despite this progress, experts caution that deep-seated mistrust and unresolved disputes remain. Non‑tariff barriers, such as technology export restrictions and visa policies, continue to loom. Chinese officials emphasised the deal’s provisional nature, awaiting “balanced” steps by both sides.

Analyst Ian Bremmer of Eurasia Group observed that while restarting the Geneva truce is a step up from breakdown, achieving a durable U.S.-China trade relationship will require sustained engagement and policy alignment. The role of rare earths as leverage underscores China’s global strategic advantage.

President Trump signalled confidence that approval could occur swiftly: Lutnick suggested sign-off might happen within days, as early as Wednesday or Thursday, after which implementation could begin. However, both governments have set a firm deadline of 10 August to negotiate a broader accord, before tariffs revert to higher levels.

With economic growth at risk from disrupted supply chains and tense trade anomalies, both the White House and Beijing face pressure to deliver tangible results. The World Bank recently warned that heightened tariff uncertainty could drag down global growth to an estimated 2.3 per cent in 2025.

While the deal hasn’t resolved core security‑driven trade issues—such as semiconductor and aviation export controls—it marks a notable thaw in tensions. Trump labelled his relationship with Xi as “excellent”, while both leaders exchanged invitations for state visits, signalling a diplomatic openness that has been absent from U.S.-China relations.

MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates.

Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022.

MediLink’s strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors.

CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink’s valuation and widening investor interest both locally and abroad.

While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms.

Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma.

The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink’s balance sheet.

The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings.

MediLink’s choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital.

Stakeholder sentiment appears optimistic. MediLink’s management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li’s appointment as CFO in 2023 reportedly strengthened the company’s capital market readiness.

Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment.

MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong’s Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support.

Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink’s corporate profile. For banks, it reinforces Hong Kong’s appeal as a biotech capital market when compared with established centres like Nasdaq.

With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.

The UAE Ministry of Finance convened an impactful awareness session in Shanghai for Emirati students pursuing studies in China, spotlighting pathways into international financial institutions and multilateral development bodies. The event, held at the Shanghai headquarters of the New Development Bank, marked a central component of the UAE’s “UAE Global Cadres” initiative aimed at preparing nationals for careers in global finance.

Attended by prominent figures including H.E. Muhannad Sulaiman Al Naqbi, Consul General in Shanghai; Thuraiya Hamid Alhashmi, Director of International Financial Relations; and Qiangwu Zhou, Vice‑President and CAO of the NDB, the session featured detailed presentations on recruitment, training mechanisms, and institutional roles in multilateral settings. Ali Abdullah Sharafi, Acting Assistant Undersecretary for International Financial Relations, highlighted the Ministry’s commitment to “creating an interactive environment that brings together young Emirati talent with influential international organisations”.

With a focus on introducing students to specific roles within institutions such as the New Development Bank, the discussion covered NDB’s core mission of financing infrastructure and sustainable development projects across member countries. Students were provided an in-depth look at the Bank’s internal functions, including strategic planning, project financing, and administrative operations—areas in which career prospects are steadily rising. Qiangwu Zhou shed light on NDB’s expansion and strengthening of its global talent pipeline, reinforcing the UAE’s active role in its leadership and operations.

The session formed part of a wider programme under the “UAE Global Cadres” framework, which seeks to empower Emirati youth with the knowledge and contacts necessary for onboarding into premier international financial institutions. The initiative offers customised introductions, tailored knowledge development, and structured partnerships with organisations like the NDB alongside other global bodies.

Ahli Emirati scholars heard how the Ministry actively forges linkages with multilateral entities, not only to open doors for internships and secondments but also to embed nationals within strategic policy and operational roles. Students were briefed on specific entry requirements, including academic credentials, language proficiency, internship prerequisites, and application timelines. The Ministry emphasised its role as a facilitator, guiding candidates from initial interest through to successful placement.

The Shanghai session aligns with similar outreach efforts previously held in London and Washington, forging a consistent global strategy. In London, Home Office-led seminars engaged Emiratis studying in the UK, while in Washington, the Ministry together with representatives from the World Bank and IMF provided insights into recruitment and professional development frameworks.

Officials confirmed that up to 100 Emirati students participated in the Shanghai event. These attendees represent a cross-section of postgraduate candidates in disciplines such as economics, finance, development studies, and public policy. The Ministry has underlined its ambition for the programme to scale further, expanding to additional locations and engaging larger cohorts.

By nurturing talent domestically and internationally, the UAE aims to enhance its representation within global financial institutions and multilateral banks. This strategy dovetails with broader national goals: positioning Emiratis as influential actors on the world stage and ensuring the nation’s contribution to international finance is both substantive and sustainable.

Strategic partnerships with institutions like the NDB are vital in this respect. Established by BRICS nations in 2014, the NDB is undergoing rapid growth, investing in global operations while seeking multilingual professionals with cross-cultural acumen. For UAE nationals, the Bank offers a rare opportunity to join a rising multilateral institution from an early stage in its trajectory. According to NDB’s Vice-President Zhou, Emirati contributions at organisational and governance levels are steadily increasing.

Students raised questions about the logistics of recruitment, including timelines, evaluation methodologies, and integration approaches. Officials emphasised the importance of early engagement, noting that securing internships during or immediately after academic studies is critical. They also recommended building competencies in project management, negotiation, and multicultural teamwork. Ministry representatives expressed that the goal extends well beyond securing roles—it is about training a generation of Emiratis capable of navigating and shaping global finance policies.

The session also included interactive elements such as Q&A panels and breakout discussions, enabling direct engagement with senior practitioners from the NDB and the Ministry. This format allowed participants to seek personalised advice on career planning, CV refinement, and interview techniques.

The broader economic context for this effort is clear: as global development finance pivots towards sustainable and inclusive projects, multilateral institutions are broadening their hiring strategies to include more diverse nationalities. Countries like the UAE are responding by investing in preparatory programmes that align local talent pipelines with evolving international demand.

This engagement echoes the Ministry’s participation in high-level forums; last August, UAE delegates attended the ninth Annual Meeting of the NDB Board of Governors in Cape Town. Thuraiya Hamid Alhashmi represented the nation on the Board alongside representatives from Egypt and Bangladesh, underscoring the UAE’s growing strategic engagement with the Bank.

Officials described the Shanghai session as “a landmark opportunity for Emirati students to learn first-hand about global finance careers” and signposted further events planned in Europe and North America. The Ministry stressed that participation is not limited to finance graduates—disciplines including law, environmental policy, and engineering are also relevant to multilateral institution operations.

The new wave of global finance, driven by sustainability goals and digital transformation, requires professionals with a hybrid skill set: technical competence, policy insight, cultural intelligence, and legal understanding. The Ministry’s programme aims to sculpt Emirati candidates who meet these multifaceted demands, thereby positioning them as competitive contenders in the international talent ecosystem.